Drugs / OROS-Methylphenidate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2/3 | NCT01853280 Background | May 2014 → Feb 2017 | attention deficit-hyperactivity disorder | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01533493 Comparator | May 2012 → Jul 2013 | attention deficit-hyperactivity disorder | Massachusetts General Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OROS-Methylphenidate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01533493 ↗ |